---
layout: center
transition: fade-out
---

# [AMS Techniques]{.gradient-text}

<!-- CSS styling for .gradient-text class -->
<style>
    .gradient-text {
      background: linear-gradient(-45deg, rgb(11, 104, 134), rgb(9, 131, 172));
      -webkit-background-clip: text;
      -moz-background-clip: text;
      -webkit-text-fill-color: transparent;
      -moz-text-fill-color: transparent;
      font-size: 2em; 
    }
   
</style>

---
layout: default
---
<CircleShape position="top:20%; left:-5%; size:80px; color:rgba(3, 80, 105, 0.55)" />
<PillShape position="bottom:1%; right:1%; width:10%; height:20px; color:rgba(33,150,243,0.08)" />

## [Front-End vs Back-End Interventions]{.text-teal-400}

<br>


<div class="grid grid-cols-2 gap-8">

<!-- Left Column: Pre-Authorization -->
<v-click>
<div class="border-r border-gray-200 pr-4">

### 🔒 Front-End Strategy (Pre-Authorization)

Approval are required before prescribing certain antibiotics  

**Who approves:**  
• Medical Doctor
• Pharmacist  

**Pros:**  
✓ Immediate control of high-risk drugs  
✓ Prevents inappropriate use upfront  

**Cons:**  
✗ May delay therapy in emergencies  
✗ Adds administrative burden  

**Example:**  
Restrict Reserve antibiotics like carbapenems  
</div>

</v-click>

<!-- Right Column: Audit & Feedback -->
<v-click>

<div class="pl-4">

### 🔍 Back-End Strategy (Audit & Feedback)

This is the Review of antibiotic use after initiation  

**Who reviews:**  
• Pharmacist  
• Stewardship team  

**Pros:**  
✓ Prescriber autonomy is preserved  
✓ High acceptance and educational value  

**Cons:**  
✗ Labor-intensive  
✗ Slower impact (48–72 hours)  

**Example:**  
Daily "time-out" rounds in ICU  
</div>
</v-click>

</div>

---
layout: default
---

<CircleShape position="top:20%; left:-5%; size:80px; color:rgba(3, 80, 105, 0.55)" />
<PillShape position="bottom:1%; right:1%; width:10%; height:20px; color:rgba(33,150,243,0.08)" />

## Evidence & Outcomes

<v-clicks>

- Both strategies are core components of ASPs

- ***Hybrid models are common:***

- Pre-auth works well for Reserve drugs

- Audit/feedback is usuallypracticed on broad-spectrum use

- Studies show reduced resistance and improved prescribing behaviour

</v-clicks>

---
layout: default
---


<CircleShape position="top:20%; left:-5%; size:80px; color:rgba(3, 80, 105, 0.55)" />
<PillShape position="bottom:1%; right:1%; width:10%; height:20px; color:rgba(33,150,243,0.08)" />


## The “4 Ds” of Antimicrobial Prescribing


<div class="mt-12 grid grid-cols-2 gap-8">

<!-- Left Column - appears on first click -->
<v-click>
<div class="mt-5 pr-4">

### 💊 1. Right Drug

- Select the most targeted antimicrobial/antibiotic for the infection.

- Avoid broad-spectrum agents unless absolutely necessary.
- Consider local resistance patterns and patient allergies.
</div>
</v-click>

<!-- Right Column - appears on same click as left column -->
<v-click>
<div class="mt-5 pl-4">

### 📏 2. Right Dose

- Tailor the dose to:

- Patient weight
- Renal and hepatic function
- Severity of infection
- Underdosing risks treatment failure; overdosing risks toxicity.
</div>
</v-click>

</div>
<v-click>

- *Example: Use nitrofurantoin for uncomplicated urinary tract infections instead of a fluoroquinolone like ciprofloxacin.*

</v-click>
---
layout: default
---

<CircleShape position="top:20%; left:-5%; size:80px; color:rgba(3, 80, 105, 0.55)" />
<PillShape position="bottom:1%; right:1%; width:10%; height:20px; color:rgba(33,150,243,0.08)" />


## The “4 Ds” of Antimicrobial Prescribing

<div class="mt-12 grid grid-cols-2 gap-8">

<!-- Left Column -->
<v-click>
<div class="pr-4">

### ⏳ 3. Right Duration

- Prescribe for the shortest effective course possible.

- Overly long durations increase risk of resistance and side effects.

- Reassess therapy at 48–72 hours and adjust based on clinical response.

- *Example: Community-acquired pneumonia often requires 5–7 days, not 10+.*

</div>
</v-click>

<!-- Right Column -->
<v-click>
<div class="pl-4">

### 🔄 4. De-escalation

- Once culture and susceptibility results are available:

- Stop unnecessary antibiotics

- Switch from broad-spectrum to narrow-spectrum agents

- De-escalation reduces collateral damage to the microbiome and lowers resistance risk.

- *Example: If vancomycin was started empirically for MRSA, but cultures show MSSA, switch to nafcillin or cefazolin5.*

</div>

</v-click>

</div>